Although we only tested the IFN-γ release assay in one HLA-A2+ PPD− volunteer, and could not draw a conclusion from the results of our experiment, it is possible that these peptides have the potential to be used for TB diagnosis. This evidence concerns the gene IFNG and tuberculosis.